首页> 美国卫生研究院文献>Journal of Virology >Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A
【2h】

Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A

机译:Polo样激酶1通过过度磷酸化NS5A参与丙型肝炎病毒复制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatitis C virus (HCV) replication involves many viral and host factors. Here, we employed a lentivirus-based RNA interference (RNAi) screening approach to search for possible cellular factors. By using a kinase-phosphatase RNAi library and an HCV replicon reporter system, we identified a serine-threonine kinase, Polo-like kinase 1 (Plk1), as a potential host factor regulating HCV replication. Knockdown of Plk1 reduced both HCV RNA replication and nonstructural (NS) protein production in both HCV replicon cells and HCV-infected cells while it did not significantly affect host cellular growth or cell cycle. Overexpression of Plk1 in the knockdown cells rescued HCV replication. Interestingly, the ratio between the hyperphosphorylated form (p58) and the basal phosphorylated form (p56) of NS5A was lower in the Plk1 knockdown cells and Plk1 kinase inhibitor-treated cells than in the control groups. Further studies showed that Plk1 could be immunoprecipitated together with NS5A. Both proteins partially colocalized in the perinuclear region. Furthermore, Plk1 could phosphorylate NS5A to both the p58 and p56 forms in an in vitro assay system; the phosphorylation efficiency was comparable to that of the reported casein kinase. Taken together, this study shows that Plk1 is an NS5A phosphokinase and thereby indirectly regulates HCV RNA replication. Because of the differential effects of Plk1 on HCV replication and host cell growth, Plk1 could potentially serve as a target for anti-HCV therapy.
机译:丙型肝炎病毒(HCV)复制涉及许多病毒和宿主因素。在这里,我们采用了基于慢病毒的RNA干扰(RNAi)筛选方法来搜索可能的细胞因子。通过使用激酶磷酸酶RNAi文库和HCV复制子报告系统,我们确定了丝氨酸-苏氨酸激酶,Polo样激酶1(Plk1),作为调节HCV复制的潜在宿主因子。敲低Plk1可以降低HCV复制子细胞和HCV感染的细胞中的HCV RNA复制和非结构性(NS)蛋白质的产生,但不会显着影响宿主细胞的生长或细胞周期。击倒细胞中Plk1的过表达拯救了HCV复制。有趣的是,NS5A的高磷酸化形式(p58)与基础磷酸化形式(p56)之间的比率在Plk1敲低细胞和Plk1激酶抑制剂处理的细胞中比对照组要低。进一步的研究表明,Plk1可以与NS5A一起免疫沉淀。两种蛋白都部分共定位在核周区域。此外,在体外测定系统中,Plk1可以将NS5A磷酸化为p58和p56形式。磷酸化效率与报道的酪蛋白激酶相当。两者合计,这项研究表明Plk1是一种NS5A磷酸激酶,从而间接调节HCV RNA复制。由于Plk1对HCV复制和宿主细胞生长的不同影响,Plk1可能会成为抗HCV治疗的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号